IMODIUMMulti-Symptom Relief (Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division)


Welcome to the PulseAid listing for the IMODIUM drug offered from Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division
NON-PROPRIETARY NAME: loperamide hydrochloride and dimethicone
SUBSTANCE NAME: LOPERAMIDE HYDROCHLORIDE; DIMETHICONE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2008-07-01
END MARKETING DATE: 0000-00-00


IMODIUM Multi-Symptom Relief HUMAN OTC DRUG Details:

Item DescriptionIMODIUM Multi-Symptom Relief from Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division
LABELER NAME: Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division
DEA SCHEDULE:
ACTIVE STRENGTH: 2; 125(mg/1; mg/1)
START MARKETING DATE: 2008-07-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 50580-338_bb6e86bb-fee4-45b1-ab6b-d9206998f362
PRODUCT NDC: 50580-338
APPLICATION NUMBER: NDA021140

Other LOPERAMIDE HYDROCHLORIDE; DIMETHICONE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare DivisionIMODIUM